Belgium· BE-AMP-SAM662058-00
Inaqovi 35 mg - 100 mg
A decitabin, kombinationen product containing decitabine, registered in Belgium by Otsuka Pharmaceutical Netherlands. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Decitabin, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC L01BC58 (decitabin, kombinationen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Decitabin, kombinationen · ATC L01BC58
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Decitabine
- Manufacturer
- Otsuka Pharmaceutical Netherlands
- Country
- Belgium (BE)
- ATC code
- L01BC58
- ATC class
- Decitabin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Decitabin, kombinationen in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesdecitabineGland Pharma Limited
- SpainDACOGEN 50 mg polvo para concentrado para solucion para perfusionJanssen-Cilag International N.V
- NetherlandsDacogen 50 mg, poeder voor concentraat for solution voor oplossing voor infusieJanssen-Cilag International NV
- SwedenDACOGEN 50 mg Pulver till koncentrat till infusionsvätska, lösningJanssen-Cilag International NV
- FinlandDacogenOrifarm Oy
- IrelandDacogen 50 mg powder for concentrate for solution for infusionJanssen-Cilag International NV
- SwitzerlandDacogen
- NorwayDacogenJanssen-Cilag International N.V.
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Decitabin Accord, Decitabine Ever Pharma
- Bulgaria · Децитабин Ever Pharma
- Cyprus · Decitabine Accord, Decitabine Teva
- Denmark · Decitabin Teva, Decitabine "sandoz"
- Spain · Decitabina Accord, Decitabina Eugia
- Finland · Decitabine Ever Pharma
- United Kingdom (Northern Ireland) · Decitabine Hikma Farmacêutica (Portugal)
- Croatia · Decitabin Accord, Decitabine Ever Pharma
- Hungary · Decitabine Ever Pharma
- Ireland · Decitabine Accord, Decitabine Ever Pharma
- Iceland · Dacogen
- Italy · Decitabina Accord, Decitabina Aurobindo
- Liechtenstein · Dacogen
- Lithuania · Decitabine Accord, Decitabine Ever Pharma
- Latvia · Decitabine Ever Pharma
- Netherlands · Decitabine Ever Pharma, Decitabine Hikma
- Norway · Dacogen, Decitabin Teva
- Portugal · Decitabina Accord, Decitabina Eugia
- Romania · Decitabină Accord, Decitabină Sandoz
- Sweden · Decitabin Teva, Decitabine Accord
- Slovenia · Decitabin Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e049bfa3-9efe-4b5a-849d-3296a2b026b0 GET /v1/drugs/e049bfa3-9efe-4b5a-849d-3296a2b026b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Inaqovi 35 mg - 100 mg",
"name_fr": "Inaqovi 35 mg - 100 mg",
"name_nl": "Inaqovi 35 mg - 100 mg",
"amp_code": "SAM662058-00",
"strengths": [
"35.0000",
"35.0000",
"100.0000",
"100.0000",
"306.0000"
],
"pack_count": 1,
"substances": [
"Decitabine",
"Cedazuridine",
"Lactose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Decitabine, Combinations",
"authorisation_numbers": [
"EU/1/23/1756/001"
]
}See everything about decitabin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.